Follow
caterina fattorusso
Title
Cited by
Cited by
Year
Synthesis of N1-arylidene-N2-quinolyl-and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains
S Gemma, G Kukreja, C Fattorusso, M Persico, MP Romano, M Altarelli, ...
Bioorganic & medicinal chemistry letters 16 (20), 5384-5388, 2006
2502006
Histone deacetylase inhibitors in the treatment of cancer: overview and perspectives
G Giannini, W Cabri, C Fattorusso, M Rodriquez
Future medicinal chemistry 4 (11), 1439-1460, 2012
2032012
Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors
L Savini, A Gaeta, C Fattorusso, B Catalanotti, G Campiani, L Chiasserini, ...
Journal of Medicinal Chemistry 46 (1), 1-4, 2003
1842003
Paclitaxel directly binds to Bcl-2 and functionally mimics activity of Nur77
C Ferlini, L Cicchillitti, G Raspaglio, S Bartollino, S Cimitan, C Bertucci, ...
Cancer research 69 (17), 6906-6914, 2009
1812009
Non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors: past, present, and future perspectives
G Campiani, A Ramunno, G Maga, V Nacci, C Fattorusso, B Catalanotti, ...
Current pharmaceutical design 8 (8), 615-657, 2002
1632002
The seco-taxane IDN5390 is able to target class III β-tubulin and to overcome paclitaxel resistance
C Ferlini, G Raspaglio, S Mozzetti, L Cicchillitti, F Filippetti, D Gallo, ...
Cancer research 65 (6), 2397-2405, 2005
1352005
Synthesis and Pharmacological Evaluation of Potent and Highly Selective D3 Receptor Ligands:  Inhibition of Cocaine-Seeking Behavior and the Role of Dopamine D3/D …
G Campiani, S Butini, F Trotta, C Fattorusso, B Catalanotti, F Aiello, ...
Journal of medicinal chemistry 46 (18), 3822-3839, 2003
1152003
Discovery of a New Class of Potential Multifunctional Atypical Antipsychotic Agents Targeting Dopamine D3 and Serotonin 5-HT1A and 5-HT2A Receptors …
S Butini, S Gemma, G Campiani, S Franceschini, F Trotta, M Borriello, ...
Journal of medicinal chemistry 52 (1), 151-169, 2009
1022009
Specific targeting of hepatitis C virus NS3 RNA helicase. Discovery of the potent and selective competitive nucleotide-mimicking inhibitor QU663
G Maga, S Gemma, C Fattorusso, GA Locatelli, S Butini, M Persico, ...
Biochemistry 44 (28), 9637-9644, 2005
992005
Design, synthesis, and structure–activity relationship studies of 4-quinolinyl-and 9-acrydinylhydrazones as potent antimalarial agents
C Fattorusso, G Campiani, G Kukreja, M Persico, S Butini, MP Romano, ...
Journal of medicinal chemistry 51 (5), 1333-1343, 2008
962008
Development of molecular probes for the identification of extra interaction sites in the mid-gorge and peripheral sites of butyrylcholinesterase (BuChE). Rational design of …
G Campiani, C Fattorusso, S Butini, A Gaeta, M Agnusdei, S Gemma, ...
Journal of medicinal chemistry 48 (6), 1919-1929, 2005
902005
Endoperoxide derivatives from marine organisms: 1, 2-dioxanes of the plakortin family as novel antimalarial agents
C Fattorusso, G Campiani, B Catalanotti, M Persico, N Basilico, S Parapini, ...
Journal of medicinal chemistry 49 (24), 7088-7094, 2006
802006
Pyrrolo [1, 3] benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure− activity relationship studies, and identification of …
G Campiani, S Butini, C Fattorusso, B Catalanotti, S Gemma, V Nacci, ...
Journal of medicinal chemistry 47 (1), 143-157, 2004
792004
Discovery of a new series of jatrophane and lathyrane diterpenes as potent and specific P-glycoprotein modulators
E Barile, M Borriello, A Di Pietro, A Doreau, C Fattorusso, E Fattorusso, ...
Organic & Biomolecular Chemistry 6 (10), 1756-1762, 2008
732008
Novel and potent tacrine-related hetero-and homobivalent ligands for acetylcholinesterase and butyrylcholinesterase
L Savini, G Campiani, A Gaeta, C Pellerano, C Fattorusso, L Chiasserini, ...
Bioorganic & medicinal chemistry letters 11 (13), 1779-1782, 2001
712001
Exploiting protein fluctuations at the active-site gorge of human cholinesterases: further optimization of the design strategy to develop extremely potent inhibitors
S Butini, G Campiani, M Borriello, S Gemma, A Panico, M Persico, ...
Journal of medicinal chemistry 51 (11), 3154-3170, 2008
692008
Amygdaloidins A–L, twelve new 13 α-OH jatrophane diterpenes from Euphorbia amygdaloides L.
G Corea, C Fattorusso, E Fattorusso, V Lanzotti
Tetrahedron 61 (18), 4485-4494, 2005
682005
Neuronal high-affinity sodium-dependent glutamate transporters (EAATs): targets for the development of novel therapeutics against neurodegenerative diseases
G Campiani, C Fattorusso, M Angelis, B Catalanotti, S Butini, R Fattorusso, ...
Current pharmaceutical design 9 (8), 599-625, 2003
682003
Combining 4-aminoquinoline-and clotrimazole-based pharmacophores toward innovative and potent hybrid antimalarials
S Gemma, G Campiani, S Butini, BP Joshi, G Kukreja, SS Coccone, ...
Journal of medicinal chemistry 52 (2), 502-513, 2009
672009
Oxime amides as a novel zinc binding group in histone deacetylase inhibitors: synthesis, biological activity, and computational evaluation
CB Botta, W Cabri, E Cini, L De Cesare, C Fattorusso, G Giannini, ...
Journal of Medicinal Chemistry 54 (7), 2165-2182, 2011
662011
The system can't perform the operation now. Try again later.
Articles 1–20